Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 42 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
36MO Location and size of metastasectomy in melanoma patients treated with tumor-infiltrating lymphocytes (TIL) in relation to clinical outcome
M. Rohaan, T. Holz Borch,R. Kessels, C. Nijenhuis,J.H. van den Berg,B. Nuijen, I. Jedema,M. van Zon,M. Geukes Foppen,A. Torres Acosta, S. Wilgenhof, F. Lalezari,
Immuno-Oncology and Technology (2022): 100141
Cited0Views0Bibtex
0
0
Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial
J. B. A. G. Haanen, M. Rohaan, T. H. Borch,J. H. Van den Berg, ?. Met,M. Geukes Foppen, J. Stoltenborg Granhoj,B. Nuijen, C. Nijenhuis,J. H. Beijnen, I. Jedema,M. Van Zon,
ANNALS OF ONCOLOGYno. 7 (2022): S1406-S1406
Cited14Views0Bibtex
14
0
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
M W Rohaan, R Gomez-Eerland,J H van den Berg,M H Geukes Foppen,M van Zon,B Raud, I Jedema, S Scheij,R de Boer, N A M Bakker,D van den Broek, L M Pronk,
Immuno-Oncology and Technology (2022): 100089-100089
Cited8Views0WOSBibtex
8
0
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
M.W. Rohaan, R. Gomez-Eerland,J.H. van den Berg,M.H. Geukes Foppen,M. van Zon, B. Raud, I. Jedema, S. Scheij,R. de Boer, N.A.M. Bakker,D. van den Broek, L.M. Pronk,
Immuno-Oncology and Technology (2022): 100089
Cited0Views0Bibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn